Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Pharma giant to relocate research hub to Cambridge in £400m move
Pharmaceutical giant GSK has announced plans to close its main research and development hub in Stevenage, Hertfordshire, in favour of a new flagship facility in Cambridge. This strategic move is part of a broader initiative to slash costs by…
BC Partners to Buy Stake in $1.5 Billion Pharma Firm InfoRLife
BC Partners has agreed to acquire a co-control stake in Swiss pharmaceutical company InfoRLife SA, marking the second deal from its newest flagship fund. The private equity firm is buying the stake from InfoRLife Chief Executive Officer Sergio…
Exclusive: China's up-and-coming pharma giants
Chinese pharmaceutical companies are making inroads, particularly in early-stage research and initial clinical trials, but remain about a decade away from challenging industry heavyweights like AstraZeneca on a global stage, the company's chief…
Format, loading, ingredients: Sirio Pharma on tackling APAC's oral beauty market
Beauty-from-within was the second-largest category in Asia-Pacific's vitamin and dietary supplement sector last year and Sirio Pharma says it is focusing on key progress in its ingredient and dosage innovations in securing greater market shares in…
Trump's generic drug tariffs will test his pharma strategy
President Trump's planned tariffs for generic drugs are the clearest test yet of whether the administration can keep its promises to both increase U.S. drug manufacturing and lower prescription costs. Why it matters: Tariffs could give the country…
This Stock Of The Day Dines On Big Pharma Royalties; Up 56% In 2026
Ligand Pharmaceuticals Ligand Pharmaceuticals LGND $ 294.12 $6.42 2.13% 6% IBD Stock Analysis Shares could rebound from 21-day exponential line, or possible form a flat base. If stock continues lower, watch for a rebound from the 50-day moving…
.jpg)
Big Pharma Wants To Turn Toad Venom Into The Next Blockbuster Drug
Big Pharma is making a high-stakes bet that their next cash grab will come from an unlikely source: the psychedelic venom of toads. Pharmaceutical companies are pouring billions into a drug called 5-MeO-DMT, often known as bufo, a powerful…
Nuvectis Pharma (NVCT) Expected to Announce Earnings on Tuesday
Nuvectis Pharma (NASDAQ:NVCT - Get Free Report) is expected to release its Q2 2026 results before the market opens on Tuesday, August 4th. Analysts expect the company to post earnings of ($0.25) per share for the quarter. Interested persons can…
Louise Frederika Kooij Sells 105,000 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) Stock
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Get Free Report) CAO Louise Frederika Kooij sold 105,000 shares of the stock in a transaction on Monday, July 20th. The shares were sold at an average price of $30.34, for a total value of…
BridgeBio Pharma (BBIO) to Release Quarterly Earnings on Tuesday
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) is anticipated to announce its Q2 2026 results after the market closes on Tuesday, August 4th. Analysts expect BridgeBio Pharma to announce earnings of ($0.63) per share and revenue of $221.1540…
86,650 Shares in Ascendis Pharma A/S $ASND Bought by Eagle Health Investments LP
Eagle Health Investments LP bought a new stake in shares of Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 86,650 shares of…
Rock Springs Capital Management LP Acquires 24,750 Shares of BridgeBio Pharma, Inc. $BBIO
Rock Springs Capital Management LP boosted its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 23.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange…
First Trust Advisors LP Reduces Holdings in Royalty Pharma PLC $RPRX
First Trust Advisors LP lowered its stake in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 7.0% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 786,395 shares of the…
Rock Springs Capital Management LP Has $44.37 Million Holdings in Ascendis Pharma A/S $ASND
Rock Springs Capital Management LP lowered its position in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) by 4.7% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 194,000 shares of the…
Maverick Capital Ltd. Has $69.99 Million Stock Holdings in NewAmsterdam Pharma Company N.V. $NAMS
Maverick Capital Ltd. grew its stake in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 15.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The…
Receive a Daily briefing on Pharma Industry News
Get Started